Blood Res.  2015 Jun;50(2):117-118. 10.5045/br.2015.50.2.117.

Pseudo gray platelet syndrome: the first case report in Korea

• Yoo J
• Kim Y
• Han K

• KMID: 2172778
• DOI: http://doi.org/10.5045/br.2015.50.2.117

Abstract

No abstract available.

MeSH Terms

Gray Platelet Syndrome*
Korea

Figure

• 

  Fig. 1 Pseudo gray platelets. (A) Blood collected in EDTA 4 hours prior showing aggregated agranular gray platelets (arrow). (B) Blood collected into EDTA showing large and pale agranular platelets. (C) Blood collected into sodium citrate showing normally stained platelets with tiny purple granules. Blood films were prepared immediately after venipuncture (×1,000, Wright-Giemsa stain).

• 

  Fig. 2 Electron micrographs of pseudo gray platelets. (A) Blood collected into EDTA showing absence of storage granules (×15,000). (B) Blood collected into the trisodium citrate dehydrate-containing tube showing normal platelet structures, including typical α-granules (×12,000).

Reference

1. Stavem P, Berg K. A macromolecular serum component acting on platelets in the presence of EDTA--platelet stain preventing factor? Scand J Haematol. 1973; 10:202–208. PMID: 4129256.

2. Mant MJ, Doery JC, Gauldie J, Sims H. Pseudothrombocytopenia due to platelet aggregation and degranulation in blood collected in EDTA. Scand J Haematol. 1975; 15:161–170. PMID: 812172.

3. Cockbill SR, Burmester HB, Heptinstall S. Pseudo grey platelet syndrome-grey platelets due to degranulation in blood collected into EDTA. Eur J Haematol. 1988; 41:326–333. PMID: 3143601.

4. Toyota S, Nakamura N, Dan K. Pseudo gray platelet syndrome in a patient with acute myocardial infarction. Int J Hematol. 2002; 76:376–378. PMID: 12463604.

5. Nurden AT, Nurden P. The gray platelet syndrome: clinical spectrum of the disease. Blood Rev. 2007; 21:21–36. PMID: 16442192.